Davids, Matthew S.
Harvard Medical School,
United States
2025 Rank: 55670
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1064 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 55670 | 53901 |
| Total Cites | 1676 | 1899 |
| H-index | 17 | 19 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 44 | 44 |
| Total Cites to Single+First Authored Papers | 255 | 290 |
| Number of Single+First+Last Authored Papers | 77 | 77 |
| Total Cites to Single+First+Last Authored Papers | 364 | 415 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1251 | 1331 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.43 |
| Self-Citation Percentage |
11.74%
|
|
Davids, Matthew S.
Dana-Farber Cancer Institute,
United States
2024 Rank: 36008
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 749 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 36008 | 33412 |
| Total Cites | 1566 | 1872 |
| H-index | 17 | 20 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 42 | 42 |
| Total Cites to Single+First Authored Papers | 270 | 309 |
| Number of Single+First+Last Authored Papers | 68 | 68 |
| Total Cites to Single+First+Last Authored Papers | 367 | 412 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1195 | 1348 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.39 |
| Self-Citation Percentage |
16.35%
|
|
Davids, Matthew S.
Dana-Farber Cancer Institute,
United States
2023 Rank: 29554
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 689 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 29554 | 28902 |
| Total Cites | 1607 | 1940 |
| H-index | 18 | 20 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 305 | 338 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 402 | 441 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1207 | 1405 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.38 |
| Self-Citation Percentage |
17.16%
|
|
Davids, Matthew S.
Dana-Farber Cancer Institute,
United States
2022 Rank: 21996
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 592 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 21996 | 21990 |
| Total Cites | 1660 | 1996 |
| H-index | 21 | 21 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 312 | 348 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 431 | 471 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1225 | 1429 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.40 |
| Self-Citation Percentage |
16.83%
|
|
Davids, Matthew S.
Dana-Farber Cancer Institute,
United States
2021 Rank: 22586
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 572 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 22586 | 22630 |
| Total Cites | 2324 | 2771 |
| H-index | 23 | 24 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 16 | 16 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 463 | 512 |
| Number of Single+First+Last Authored Papers | 49 | 49 |
| Total Cites to Single+First+Last Authored Papers | 637 | 694 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1739 | 2023 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.37 |
| Self-Citation Percentage |
16.13%
|
|
Davids, Matthew S.
Dana-Farber Cancer Institute,
United States
2020 Rank: 25628
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 587 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 25628 | 26798 |
| Total Cites | 1135 | 1351 |
| H-index | 18 | 19 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 22 | 24 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 326 | 360 |
| Number of Single+First+Last Authored Papers | 44 | 44 |
| Total Cites to Single+First+Last Authored Papers | 422 | 468 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 809 | 903 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.50 |
| Self-Citation Percentage |
15.99%
|
|